| 摘要 |
The present invention relates to a new peptide compound or a salt thereof, which has anti-hepatits C virus activities based on inhibitory activity against the RNA replication of hepatitis C virus replicon, a process for preparation thereof, a pharmaceutical composition comprising the same, and a method for prophylactic and/or therapeutic treatment of hepatitis C in a human being or an animal. |
